For economist/biostats geeks – ctd.
Austin Frakt May 11, 2013
I thank the readers who suggested publications that might include the concept I blogged about a few days ago, the extent to which IV estimation
I thank the readers who suggested publications that might include the concept I blogged about a few days ago, the extent to which IV estimation
I’ve spoken to a number of people in the media today about the Oregon Medicaid study. On the whole, they asked excellent questions, and made
This is a joint post by Austin Frakt and Aaron Carroll. Ross Douthat has a measured and reasoned response to our support for a discussion
If you’re not into instrumental variables (IV) econometrics and/or power calculations don’t bother reading this post. I’m not even going to try to make it
Chapin White concludes his Health Affairs paper on cost shifting, “My hope is that the dynamic cost-shifting theory is hereby put to rest.” His work
We’re getting to the point where I’ve written more on this one small piece of public policy than any other. So be it. It’s fascinating.
Personalized medicine is expected to revolutionize health care by developing new molecular tools to precisely diagnose and treat the problems of individual patients. But how
I am a frequent guest on Stand Up! with Pete Dominick, which airs on Sirius/XM radio, channel 104 from 6-9AM Eastern. It immediately replays on the channel, so
The following chain of logic was suggested to me by an email exchange with Tyler Cowen:* Singapore’s health system works well. Goldhill’s proposed system is
As many of you may have heard, CMS released a ton of data today on prices. What’s it mean? What should we do about it?
Over the past 20 years, hospitals have gradually implemented many safety improvements to reduce the number of hospital-onset central line associated blood stream infections (CLABSIs).